Page last updated: 2024-08-23

ursodeoxycholic acid and Acute Relapsing Multiple Sclerosis

ursodeoxycholic acid has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Donno, A; De Masi, R; Orlando, S	1

Other Studies

1 other study(ies) available for ursodeoxycholic acid and Acute Relapsing Multiple Sclerosis

Article	Year
Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity. Annals of clinical and translational neurology, 2019, Volume: 6, Issue:11 Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Comorbidity; Dimethyl Fumarate; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon beta-1a; Multiple Sclerosis, Relapsing-Remitting; Mutation; Natalizumab; Ursodeoxycholic Acid	2019

Article

Year

Progressive familial intrahepatic cholestasis type-3 and multiple sclerosis: lessons from comorbidity.

Annals of clinical and translational neurology, 2019, Volume: 6, Issue:11

Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Comorbidity; Dimethyl Fumarate; Female; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon beta-1a; Multiple Sclerosis, Relapsing-Remitting; Mutation; Natalizumab; Ursodeoxycholic Acid

2019